The Mechanisms
The Ancients Reached For
Three published paradigms — endogenic pharmacology, bioelectric regeneration, the intelligence layer that holds them in coherence — each one a modern formalization of what the classical traditions intuited and named. Compound, field, and orchestration. Mechanism rendered at the level of named pathway components and peer-reviewed cascades. The science is the protagonist of this codex.
The Three Paradigms
Each paradigm has decades of peer-reviewed literature behind it. The session does not invent the science — it organizes the supervised delivery around it.
Endogenic Pharmacology
Compositions designed around the body's own regulatory architecture.
Anchored in fifty years of peer-reviewed peptide bioregulator research from the Khavinson lineage at the St. Petersburg Institute of Bioregulation and Gerontology. The discipline studies short-chain compositions that work with — not around — the body's endogenous signaling.
Bioelectric Regeneration
The field-environment paradigm. Multi-modal influence on physiological receptivity.
From Becker's regeneration current at SUNY Upstate through Levin's morphogenetic work at Tufts, anchored by the FDA's 1979 approval of PEMF for non-union bone fractures. The published literature spans four decades.
Hi-Centric-AI
The intelligence layer. Cognitive infrastructure with human authority at the center.
Software helps the Specialist personalize session selection. The human practitioner remains the decision-maker. Decision support — not autonomous administration. The constitutive frame for how intelligence is allowed to operate inside a clinical-adjacent service.
Endogenic Pharmacology
What the Khavinson lineage at the St. Petersburg Institute of Bioregulation and Gerontology formalized in the fifty-year arc of short-chain peptide research, the Sanskrit Rasayana tradition had already named: that the body operates on signals it generates itself, and that the compounds which work with those signals rather than against them produce different effects than the compounds which override them. The pathway components are modern. The architecture is ancient.
The compound tells cells what to make.
When the session compound enters the body, it does what the body already knows how to do. Short-chain bioregulators — peptides two to four amino acids long — bind tissue-specific receptors and modulate transcription within the body's own endogenous signaling architecture.
The mechanism is direct, peer-reviewed, and tissue-selective. Each compound class targets a specific regulatory axis. The names and pathways below are the published reference — the same architecture the Khavinson lineage formalized over a fifty-year arc, now decades into peer-reviewed validation.
- → Telomerase activation
- → BDNF · neuroplasticity
- → Thymic T-cell competence
- → Endothelial function
- → ECM remodeling
- → Endocrine homeostasis
From compound to phenotype, in four steps.
What unfolds inside the body once the compound enters. Named at the level of the published pathway components. Read it slowly — each step is what the body is already doing, named in the language modern science has developed for it.
- 01CompoundShort-chain bioregulator arrives2–4 amino acid peptide · Ac-X-NH₂ analog class · tissue-selective
- 02TissueTissue-specific receptor bindingPineal · cortical · thymic · vascular · dermal · gonadal axis
- 03NucleusDirect gene expression modulationChromatin accessibility · transcription factor recruitment · promoter activation
- 04PhenotypeEndogenous program executionTelomerase · BDNF · Thymalin · COL-1 · NRF2 · the body's own regulatory output
The conventional pharmacological model introduces a foreign compound that overrides cellular function. Endogenic Pharmacology is the inverse — the body's own regulatory architecture is the active agent. The bioregulator does not replace endogenous signaling. The bioregulator restores it where the supply has attenuated with age, stress, or tissue burden.
The discipline draws on fifty years of peer-reviewed work — the Khavinson Institute, the Kirov Military Medical Academy, the Petrov Research Institute of Oncology — and continues to expand across new compound classes, new tissue axes, and new delivery architectures.
Bioelectric Regeneration
From Robert Becker's regeneration-current research at SUNY Upstate through Michael Levin's morphogenetic patterning work at Tufts, anchored by the FDA's nineteen seventy-nine approval of PEMF for non-union bone fractures. The Egyptian temple instinct that the body responds to environmental fields — the burned Kyphi at sundown, the calibrated lighting of the bath chamber, the resonance of recited prayer — tracked the same physiology that modern bioelectric science formalizes. The architecture is ancient. The instrumentation is new.
The field tells cells where to act.
What the body receives in the pod is not just the compound. It is the field the compound is delivered into. Structured electromagnetic fields modulate the receptive state of cellular membranes. The membrane transduces. The mitochondrion responds. The nucleus activates.
The pathway is fully characterized across peer-reviewed literature — Becker's regeneration-current research at SUNY Upstate, Levin's morphogenetic patterning work at Tufts, the FDA's nineteen seventy-nine approval of PEMF for non-union bone fractures, four decades of mechanism research. The Egyptian temple instinct that the burned Kyphi worked differently at sundown than at noon was tracking the same physiology the modern bioelectric science formalizes.
- → Osteogenesis
- → Angiogenesis
- → Anti-inflammation
- → Dedifferentiation
- → Pattern restoration
- → ECM matrix remodeling
From field to phenotype, in four steps.
What unfolds in the membrane, the mitochondrion, the nucleus while you lie still in the pod. The bioelectric layer is the environment the body receives. Each step is named in the published mechanism literature.
- 01FieldPulsed EMF arrives75 Hz · 1.2 mT · square pulse · 50% duty cycle · burst-pulsed configuration
- 02MembraneAdenosine A2A / A3 receptor engagementCa²⁺ influx · cAMP · PI metabolism · second-messenger cascade · membrane potential shift
- 03MitochondrionMitohormesis↑ ATP throughput · ↑ ROS hormetic burst · ↑ NRF2 · ↑ PGC-1α · ↑ biogenesis · ↑ membrane potential
- 04NucleusTranscriptional activationWnt/β-catenin · Runx2 · OSX · BMP2 · COL-1 · ALP · OCN · convergent with AEDG/KED targets
The signaling pathway is fully characterized in peer-reviewed literature. The field arrives. The membrane transduces through adenosine A2A and A3 receptors. The mitochondria respond with hormetic ATP and ROS bursts and activate the NRF2 / PGC-1α biogenesis program. The nucleus activates the canonical Wnt/β-catenin – Runx2 – BMP2 cascade — the same gates the bioregulators of endogenic pharmacology have always targeted.
One mechanism. Two converging inputs. The field tells cells where to act. The bioregulator tells cells what to make. The Atumnus Cellular Optimization Center is the first practice to operate both inputs together as a single therapeutic platform.
- · Becker · regeneration current · SUNY Upstate · 1960s–1980s
- · Levin · morphogenetic code · Tufts · ongoing
- · FDA · PEMF approval · non-union bone · 1979
- · Khavinson · short-chain peptide bioregulators · 1970s–present
- · Anisimov · peptide lifespan trials · 35 years
- · Kuznik · clinical bioregulator trials · Chita Medical Academy
Hi-Centric-AI
The intelligence layer. Software that helps the Specialist personalize session selection. The human practitioner remains the decision-maker. Decision support — not autonomous administration. The constitutive frame for how intelligence is allowed to operate inside a clinical-adjacent service. This is what the classical traditions named the master's discretion — the contextual judgment that no recipe alone could capture — now augmented by the corpus retrieval the master could not previously hold in working memory.
The intelligence holds the field whole.
The Specialist runs the session.
Before you arrive, the system has read the published corpus across one hundred and ninety-six languages — the same Khavinson literature, the Becker and Levin lineage, the classical Sanskrit Rasayana texts, the Avicennan Qānūn, the Bencao Gangmu. The synthesis is configured around your specific biology. The Specialist remains the practitioner of record.
The intelligence presents what the corpus contains. The Specialist administers. The member chooses. This is what the classical traditions named the master's discretion — the contextual judgment that no recipe alone could capture — now augmented by the corpus retrieval the master could not previously hold in working memory. The intelligence is the ground on which the practice stands. Not a feature, not an assistant, not a replacement for clinical judgment.
- → Synthesis configured to the member
- → Protocol prepared before the session
- → Specialist briefed with the relevant slice
- → Patterns surfaced across the network
- → Outcomes integrated session to session
- → The Specialist's clinical authority preserved
From corpus to decision, in five steps.
What the intelligence layer is actually doing while the Specialist consults with you — across the corpus, the graph, the vector index, the synthesis layer, and the decision support that reaches the Specialist's interface before your session begins.
- 01CorpusThe field is read wholePeer-reviewed bioregulator literature · clinical trial registries · regulatory dockets · 196 languages
- 02IndexKnowledge graph + vector embeddingEntities · relationships · dense vector representations · cross-domain linkage
- 03RetrievalMember-configured synthesisMulti-hop graph traversal · RAG-style retrieval · biology-anchored query construction
- 04SynthesisThe relevant slice surfacesPattern integration · cross-axis reasoning · protocol composition · evidence trail preserved
- 05DecisionThe Specialist receives the briefDecision-support — not decision-making · the practitioner of record runs the session
The intelligence is not bolted onto the practice — the practice is built on the intelligence. Other longevity centers operate the conventional way and add an AI assistant. The Atumnus Cellular Optimization Center operates on a Hi-Centric Intelligence substrate that reads the field whole and configures the synthesis around the member before the session begins.
The constitutive principle is the inversion of autonomous AI: the human practitioner remains the decision-maker. atumnus presents the field. The Specialist administers the protocol. The member chooses what to do with what they see.
Three Paradigms · One Closed Loop
The field tells cells where to act. The bioregulator tells cells what to make. The intelligence configures the synthesis before the session begins. Together they form a single therapeutic architecture, operated as one platform by one credentialed Specialist for one member at a time.
The three paradigms converge on the canonical Wnt/β-catenin — Runx2 — BMP2 program at the nucleus. The same gates the bioregulator compositions target through binding, that the field activates through mitohormesis, that the intelligence layer synthesizes across both inputs for each specific member. The architecture is published. The orchestration is the Center.
The compositions trace to six millennia of primary-source documentation.
VetusKodex™ designates the corpus of classical and pre-modern medicinal compound preparations under empirical translation, cross-validation, and engineering reconstruction within endogenic pharmacology. Approximately six thousand years of primary-source documentation across multiple independent civilizational traditions — cuneiform, Egyptian hieratic, Sanskrit, classical Arabic-Persian, classical Chinese, Korean — cross-validated against Atumnus molecular databases spanning millions of characterization points.
The compositions delivered through the Cellular Optimization Session trace to specifications recovered within this corpus. The session does not invent the science — it organizes the supervised delivery of compounds whose specifications were preserved across millennia of empirical pre-modern practice and recovered through eight analytical and translation capability stacks documented in the public corpus.
We point at the published lineage. We don't make the leap.
The session is designed around what the science describes. What the session does for any given person is between that person, their Specialist, and time. Cellular Optimization is a premium wellness service — not a medical treatment, diagnosis, or therapy.